$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
阿那格雷(Anagrelide)详细说明书:适应症、用法用量、副作用、注意事项
2025-10-19 11:44:20
Check Details
阿那格雷(Anagrelide)在国内上市了吗?
2025-10-19 11:44:20
Check Details
FDA授予CA-4948孤儿药称号,用于急性髓系白血病和骨髓增生异常综合征
2025-10-19 11:44:20
Check Details
Motixafortide可有效改善多发性骨髓瘤患者的造血干细胞动员
2025-10-19 11:44:20
Check Details
Melflufen治疗多发性骨髓瘤与泊马度胺相比具有非劣效性
2025-10-19 11:44:20
Check Details
FDA批准Cilta-Cel优先审查用于复发/难治性多发性骨髓瘤
2025-10-19 11:44:20
Check Details
新型三联方案治疗骨髓增生异常综合征|老年AML/MDS安全有效
2025-10-19 11:44:20
Check Details
为什么Trilaciclib能够帮助患者减轻化疗后骨髓抑制的副作用呢?
2025-10-19 11:44:20
Check Details
CA-4948治疗复发/难治性AML和MDS的早期反应
2025-10-19 11:44:20
Check Details
FDA授予维奈托克/阿扎胞苷治疗骨髓增生异常综合征突破性疗法称号
2025-10-19 11:44:20
Check Details
口服地西他滨/Cedazuridine治疗MDS和CMML可显著延长总生存期
2025-10-19 11:44:20
Check Details
Luspatercept治疗低危骨髓增生异常综合征可产生持久缓解
2025-10-19 11:44:20
Check Details
1
2
...
825
826
827
828
829
830
831
...
940
941
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Selinexor: Dosing, Food, and Safety
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Key points for drug monitoring of Molotinib in bone marrow fibrosis
5
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
6
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
7
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
8
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
9
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
10
Revumenib: Key Considerations Before and During Treatment
11
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
12
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use